The board of directors, composed of seven members, is the Company´s decision-making body responsible for formulating general directives and business guidelines, including offering guidance on its long-term strategies.

The members are appointed for a period of two years and may be reelected. Decisions of the board of directors are adopted by a majority vote of the directors present or represented at such meeting.

Founder and Executive Chairman of the Board
Ruben Minski, founder and Executive Chairman of the Board of Directors of Procaps Group, with extensive experience and recognition in the pharmaceutical industry. Chemical Engineer from Northeastern University in Boston, Massachusetts, he participated in the Owners/President Management program at Harvard University - School of Business, CEOs' II: The Next Step in Strategic Management and in the CEOs' Management Program at Kellogg School of Management at Northwestern University, USA.
Independent Director
  • 15 years of experience in public markets investing and SPAC management, and direct equity and debt private markets principal investing, capital raising, and investment banking
  • Founder and Chief Executive Officer of Union Acquisition Group and Independent Director NASDAQ: BIOX and NASDAQ: PROC.
  • Served as Chief Executive Officer Director at Union Acquisition Corp II (Nasdaq: LATIN)
  • Currently serves as an Independent Director of Bioceres Crop Solutions (NYSE: BIOX) and Procaps Group (NASDAQ: PROC) and was formerly CEO and Director of Union Acquisition Corp. (NYSE: LTN) and CEO and Director of Union Acquisition Corp. II (Nasdaq:LATN).
  • Finance, Economics from American University - Kogod School of Business
Independent Director
Independent Director
  • 28 years of experience in the financial, construction, infrastructure and agroindustry sectors
  • Served as CEO of Banco de Comercio Exterior de Colombia S.A., Colombia's development bank, and Agrodex International SAS
  • Currently serves as Director on the boards of Tecnoglass, Accenorte S.A.S. and Devimed S.A.S.
  • B.S. in Mathematics from Fordham University, B.S. in Industrial Engineering from Columbia University and MBA from the Universidad de los Andes Bogota in Colombia
Independent Director
Independent Director
  • 20+years of experience in global healthcare and pharma companies with a successful track record in value-creating transactions, international business, strategic planning, and mergers and acquisitions of public and private companies
  • Previously, served as Board Member of several private and listed companies, including CFR Pharmaceuticals S.A., Clínica Las Condes S.A. and Chairman of the Board of Laboratorio Chile S.A
  • Master’s in Commercial Law from Duke University School of Law
  • 35+ years of experience working in the health, wellness and consumer goods sectors
  • Co-founder of WM Partners, a middle-market private equity firm focused on the health and wellness industry
  • Board member of Grupo Procaps, Gelco Gelatin and Descafecol B.S. in Management Engineering from Worcester Polytechnic Institute and a Certificate in Mergers and Acquisitions from the Kellogg School of Management
Independent Director
  • 35+ years of experience in steering mature, start-up, and turn-around/restructuring enterprises toward tangible, sustainable growth within diverse international markets
  • President and CEO of PharmAdvice, a consulting firm offering pharmaceutical, medical device and biotech guidance to healthcare companies entering or operating in Mexico
  • Director on the board of directors of Fenix Holding and Farmapiel, specifically holding the title of chair of the nominations, compensation, and governance committee at Fenix Holding, in addition to serving as a regional board member of Grupo Financiero Banorte
  • Previously, she oversaw oncology operations for the North LatAm region at Novartis
  • Former chair of the Pharma Industry Trade Association (AMIIF) in Mexico
  • Worked at several of the world’s leading pharmaceutical companies, including as president of Biogen’s Mexico affiliate, general manager, and country president for Amgen Inc., and as CEO of Probiomed
  • B.S. in business administration at Universidad Intercontinental in Mexico City, Mexico
Independent Director
Independent Director
  • 20+ years of experience in the mining and energy industries
  • President at Cerrito Capital, an investment banking firm focused on the Colombian mining and energy sectors
  • Served as General Manager at Colgener S.A. and also as Director of Investment Banking at Corfivalle
  • Currently serves as a Director on the boards of Ocensa, Celsia, Oriente S.A., Credifamilia, Unimed Pharmaceuticals and Dynamo Producciones. Also involved as a Director of the Best Buddies Foundation
  • Master in Economics from London School of Economics; B.S. in Industrial Engineering from Universidad de Los Andes
Independent Director

Investor Contact Information


Procaps Group
9 Rue De Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

Investor Relations

Procaps Group Company Contact
Melissa Angelini
Investor Relations Director

Search Investor Relations